Skip to main content
Utility menu
Donate
Join
Member Login
Search
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Careers
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
WCLC 2024 Highlights
Access Online Learning
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Scientific Projects
Scientific Projects
IASLC Staging Project: Lung Cancer, Thymic Tumors, and Mesothelioma
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Past IASLC Scientific Projects
Lung Cancer 360
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Early-Career Opportunities
IASLC Academy
IASLC Academy
Amazing Case Race 2024
Publications, Resources & Guidelines
News
News
ILCN
WCLC 2024 News
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
IASLC Partnerships
Patient Advocacy
Patient Advocacy
STARS
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 217 - 228 items out of 283 results
ILCN article
Recurrence Remains a Risk Even for Patients Diagnosed via Screening
ILCN article
Food as Medicine: Research Aims to Understand the Power of Nutrition in Treating Cancer
ILCN article
Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question
ILCN article
Regulating Artificial Intelligence
ILCN article
Experts Debate Addition of Frontline Chemotherapy for EGFR+ NSCLC
ILCN article
Should Biomarkers Be Used in the Clinical Management of ES-SCLC?
ILCN article
FLAURA 2 Post-progression Outcomes Demonstrate Consistent Benefit, Favor Combination Arm
ILCN article
Antibody Drug Conjugates: Diamonds in the Rough?
ILCN article
The Promise of Artificial Intelligence-Aided Pathology in Thoracic Oncology
ILCN article
Challenges of Systemic Therapy for Patients with EGFR-mutated Lung Cancer After Progression on Targeted Therapy
ILCN article
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
ILCN article
MARIPOSA-2 Post-progression Analysis Favors Amivantamab-Chemotherapy Combination
Pagination
First
First page
‹
Previous page
…
15
16
17
18
19
20
21
22
23
…
›
Next page
Last
Last page